Medyczne Centrum Hetmanska

At Medyczne Centrum Hetmanska in Poznan, a large share of the research focuses on immune system diseases, especially systemic lupus erythematosus, lupus nephritis, and psoriatic arthritis. These studies are designed to test new treatment options, measure how well they control disease activity, and assess long-term safety.

• Systemic lupus erythematosus and related forms, with a focus on improving disease control and response rates
• Lupus nephritis, studying treatments aimed at protecting kidney function
• Psoriatic arthritis, including therapies for active disease and biologic-naive patients

The site is also involved in research on immune system processes, reflecting interest in how these conditions develop and how treatment response can be better understood.

Research in musculoskeletal diseases at this health care site includes rheumatoid arthritis, axial spondyloarthritis, and knee osteoarthritis. The trials aim to evaluate whether new therapies can reduce pain, improve mobility, and provide better symptom relief for people living with chronic joint disease.

• Rheumatoid arthritis, including studies in newly diagnosed and moderately active disease
• Axial spondyloarthritis, with attention to long-term safety and tolerability of treatment
• Knee osteoarthritis, focusing on pain reduction and functional improvement

This work shows a strong emphasis on both inflammatory joint disorders and degenerative joint disease, with the goal of improving everyday quality of life.

The research portfolio also covers skin and connective tissue diseases, including systemic sclerosis and related autoimmune conditions. Studies in this area are exploring whether new treatments can slow disease progression, ease symptoms, and improve organ-related outcomes such as lung function.

• Systemic sclerosis, with interest in broader symptom control and organ protection
• Autoimmune connective tissue disease research linked to lupus and inflammatory overlap conditions
• Therapies intended to improve long-term disease management and patient outcomes

The Poznan site contributes to research that aims to expand treatment choices for complex autoimmune disorders affecting the skin and connective tissues.

In the area of nutritional and metabolic diseases, the site is studying obesity, often alongside knee osteoarthritis. These trials are focused on evaluating whether new approaches can support weight reduction and help relieve joint pain, especially in people whose mobility is affected by excess body weight.

• Obesity, with research aimed at improving weight-related health outcomes
• Osteoarthritis linked to obesity, examining pain and functional symptoms
• Supportive treatment strategies that combine symptom relief with broader metabolic health goals

This adds a practical prevention and symptom-management dimension to the broader autoimmune and rheumatology research at Medyczne Centrum Hetmanska.